Cargando…

Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell

PURPOSE: Elevation of IOP in POAG is thought to involve excessive accumulation of extracellular matrix in the trabecular meshwork (TM), leading to an increase in outflow resistance of the aqueous humor. Osthole, a coumarin derivative extracted from the fruit of a variety of plants, such as Cnidium m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yuchen, Wei, Jiahong, Guo, Li, Zhao, Siyu, Xu, Chenyu, Sun, Hao, Guo, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445364/
https://www.ncbi.nlm.nih.gov/pubmed/32821914
http://dx.doi.org/10.1167/iovs.61.10.38
_version_ 1783573976055808000
author Fan, Yuchen
Wei, Jiahong
Guo, Li
Zhao, Siyu
Xu, Chenyu
Sun, Hao
Guo, Tao
author_facet Fan, Yuchen
Wei, Jiahong
Guo, Li
Zhao, Siyu
Xu, Chenyu
Sun, Hao
Guo, Tao
author_sort Fan, Yuchen
collection PubMed
description PURPOSE: Elevation of IOP in POAG is thought to involve excessive accumulation of extracellular matrix in the trabecular meshwork (TM), leading to an increase in outflow resistance of the aqueous humor. Osthole, a coumarin derivative extracted from the fruit of a variety of plants, such as Cnidium monnieri, is reported to prevent profibrotic responses by inhibiting Smad signaling pathway activated by TGF-β in liver, kidney, and cardiac tissues. We tested if osthole can (1) inhibit TGF-β2–induced extracellular matrix expression in cultured human TM (HTM) cells, and (2) lower TGF-β2–induced ocular hypertension in the mouse. METHODS: Cultured HTM cells were treated with 5 ng/mL TGF-β2 for 48 hours, then with osthole for 24 hours. The expressions of fibronectin, collagen type IV, and laminin were assessed by quantitative PCR, Western blot, and immunocytochemistry. BALB/cJ mice were injected intravitreally with an adenoviral vector encoding a bioactive mutant of TGF-β2 (Ad.hTGF-β2(226/228)) in one eye to induce ocular hypertension, with the uninjected contralateral or Ad.Empty-injected eye serving as controls. Mice were then treated with a daily intraperitoneal injection of 30 mg/kg osthole. Conscious mouse IOP values were measured using a TonoLab rebound tonometer. RESULTS: In cultured HTM cells, stimulation with TGF-β2 increased expressions of fibronectin, collagen IV, and laminin. These in vitro changes were significantly and completely mitigated by osthole (10 µM). Daily intraperitoneal injections of 30 mg/kg osthole, starting either at day 0 (same day as Ad.hTGF-β2226/228 injection) or at day 14, significantly decreased TGF-β2–induced ocular hypertension in the mouse. In contrast, osthole did not affect IOP of control eyes. CONCLUSIONS: These results demonstrated that osthole is capable of reducing TGF-β2–induced extracellular matrix expression in cultured HTM cells. It also reduced TGF-β2–induced ocular hypertension in the mouse. These findings indicate that this natural product may be useful as a novel treatment for POAG.
format Online
Article
Text
id pubmed-7445364
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-74453642020-09-02 Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell Fan, Yuchen Wei, Jiahong Guo, Li Zhao, Siyu Xu, Chenyu Sun, Hao Guo, Tao Invest Ophthalmol Vis Sci Glaucoma PURPOSE: Elevation of IOP in POAG is thought to involve excessive accumulation of extracellular matrix in the trabecular meshwork (TM), leading to an increase in outflow resistance of the aqueous humor. Osthole, a coumarin derivative extracted from the fruit of a variety of plants, such as Cnidium monnieri, is reported to prevent profibrotic responses by inhibiting Smad signaling pathway activated by TGF-β in liver, kidney, and cardiac tissues. We tested if osthole can (1) inhibit TGF-β2–induced extracellular matrix expression in cultured human TM (HTM) cells, and (2) lower TGF-β2–induced ocular hypertension in the mouse. METHODS: Cultured HTM cells were treated with 5 ng/mL TGF-β2 for 48 hours, then with osthole for 24 hours. The expressions of fibronectin, collagen type IV, and laminin were assessed by quantitative PCR, Western blot, and immunocytochemistry. BALB/cJ mice were injected intravitreally with an adenoviral vector encoding a bioactive mutant of TGF-β2 (Ad.hTGF-β2(226/228)) in one eye to induce ocular hypertension, with the uninjected contralateral or Ad.Empty-injected eye serving as controls. Mice were then treated with a daily intraperitoneal injection of 30 mg/kg osthole. Conscious mouse IOP values were measured using a TonoLab rebound tonometer. RESULTS: In cultured HTM cells, stimulation with TGF-β2 increased expressions of fibronectin, collagen IV, and laminin. These in vitro changes were significantly and completely mitigated by osthole (10 µM). Daily intraperitoneal injections of 30 mg/kg osthole, starting either at day 0 (same day as Ad.hTGF-β2226/228 injection) or at day 14, significantly decreased TGF-β2–induced ocular hypertension in the mouse. In contrast, osthole did not affect IOP of control eyes. CONCLUSIONS: These results demonstrated that osthole is capable of reducing TGF-β2–induced extracellular matrix expression in cultured HTM cells. It also reduced TGF-β2–induced ocular hypertension in the mouse. These findings indicate that this natural product may be useful as a novel treatment for POAG. The Association for Research in Vision and Ophthalmology 2020-08-21 /pmc/articles/PMC7445364/ /pubmed/32821914 http://dx.doi.org/10.1167/iovs.61.10.38 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Glaucoma
Fan, Yuchen
Wei, Jiahong
Guo, Li
Zhao, Siyu
Xu, Chenyu
Sun, Hao
Guo, Tao
Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title_full Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title_fullStr Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title_full_unstemmed Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title_short Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
title_sort osthole reduces mouse iop associated with ameliorating extracellular matrix expression of trabecular meshwork cell
topic Glaucoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445364/
https://www.ncbi.nlm.nih.gov/pubmed/32821914
http://dx.doi.org/10.1167/iovs.61.10.38
work_keys_str_mv AT fanyuchen ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT weijiahong ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT guoli ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT zhaosiyu ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT xuchenyu ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT sunhao ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell
AT guotao ostholereducesmouseiopassociatedwithamelioratingextracellularmatrixexpressionoftrabecularmeshworkcell